Abgentis

UK-based, early-stage biopharma developing small molecule DNA coiling inhibitors against drug resistant infections

placeAbingdon, England, United Kingdom calendar_todayFounded 2012 groups2 employees language abgentis.com

Registered entities

Innovation

1 patent family; filing pace dormant.

YearFilings
20141

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital229%
Other / undisclosed571%
Coming soon